These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29659924)

  • 21. Rotavirus immunoglobulin a responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccine.
    Ward RL; Bernstein DI; Smith VE; Sander DS; Shaw A; Eiden JJ; Heaton P; Offit PA; Clark HF
    J Infect Dis; 2004 Jun; 189(12):2290-3. PubMed ID: 15181577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh.
    Zaman K; Yunus M; El Arifeen S; Azim T; Faruque AS; Huq E; Hossain I; Luby SP; Victor JC; Dallas MJ; Lewis KD; Rivers SB; Steele AD; Neuzil KM; Ciarlet M; Sack DA
    Vaccine; 2012 Apr; 30 Suppl 1():A94-100. PubMed ID: 22520143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial.
    Zaman K; Fleming JA; Victor JC; Yunus M; Bari TI; Azim T; Rahman M; Mowla SM; Bellini WJ; McNeal M; Icenogle JP; Lopman B; Parashar U; Cortese MM; Steele AD; Neuzil KM
    J Infect Dis; 2016 Jun; 213(11):1686-93. PubMed ID: 26823338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
    Moon SS; Groome MJ; Velasquez DE; Parashar UD; Jones S; Koen A; van Niekerk N; Jiang B; Madhi SA
    Clin Infect Dis; 2016 Jan; 62(2):157-65. PubMed ID: 26400993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study.
    Omenaca F; Sarlangue J; Szenborn L; Nogueira M; Suryakiran PV; Smolenov IV; Han HH;
    Pediatr Infect Dis J; 2012 May; 31(5):487-93. PubMed ID: 22228231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants.
    Steele AD; Reynders J; Scholtz F; Bos P; de Beer MC; Tumbo J; Van der Merwe CF; Delem A; De Vos B
    J Infect Dis; 2010 Sep; 202 Suppl():S93-100. PubMed ID: 20684724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine.
    de Whalley PC; Snape MD; Kelly DF; Banner C; Lewis S; Diggle L; John TM; Yu LM; Omar O; Borkowski A; Pollard AJ
    Pediatr Infect Dis J; 2011 Nov; 30(11):e203-8. PubMed ID: 21673612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breastfeeding linked to the reduction of both rotavirus shedding and IgA levels after Rotarix® immunization in Mexican infants.
    Bautista-Marquez A; Velasquez DE; Esparza-Aguilar M; Luna-Cruz M; Ruiz-Moran T; Sugata K; Jiang B; Parashar U; Patel M; Richardson V
    Vaccine; 2016 Oct; 34(44):5284-5289. PubMed ID: 27663670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants.
    Chilengi R; Simuyandi M; Beach L; Mwila K; Becker-Dreps S; Emperador DM; Velasquez DE; Bosomprah S; Jiang B
    PLoS One; 2016; 11(3):e0150100. PubMed ID: 26974432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and safety of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine (PRV) in Indian infants.
    Lokeshwar MR; Bhave S; Gupta A; Goyal VK; Walia A
    Hum Vaccin Immunother; 2013 Jan; 9(1):172-6. PubMed ID: 23442588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau.
    Fisker AB; Ravn H; Rodrigues A; Østergaard MD; Bale C; Benn CS; Aaby P
    Vaccine; 2014 Jan; 32(5):598-605. PubMed ID: 24325827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the Micronutrient and Environmental Enteric Dysfunction Assessment Tool and evaluation of biomarker risk factors for growth faltering and vaccine failure in young Malian children.
    Arndt MB; Cantera JL; Mercer LD; Kalnoky M; White HN; Bizilj G; Boyle DS; de Hostos EL; Choy RKM
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008711. PubMed ID: 32997666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants.
    Rongsen-Chandola T; Strand TA; Goyal N; Flem E; Rathore SS; Arya A; Winje BA; Lazarus R; Shanmugasundaram E; Babji S; Sommerfelt H; Vainio K; Kang G; Bhandari N
    Vaccine; 2014 Aug; 32 Suppl 1():A134-9. PubMed ID: 25091668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
    Goujon C; Gougeon ML; Tondeur L; Poirier B; Seffer V; Desprès P; Consigny PH; Vray M;
    Vaccine; 2017 Oct; 35(45):6166-6171. PubMed ID: 28958813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine--a randomized trial.
    Ali A; Kazi AM; Cortese MM; Fleming JA; Moon S; Parashar UD; Jiang B; McNeal MM; Steele D; Bhutta Z; Zaidi AK
    PLoS One; 2015; 10(6):e0127622. PubMed ID: 26035743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India.
    Ella R; Bobba R; Muralidhar S; Babji S; Vadrevu KM; Bhan MK
    Hum Vaccin Immunother; 2018 Jul; 14(7):1791-1799. PubMed ID: 29543547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine.
    Danchin M; Kirkwood CD; Lee KJ; Bishop RF; Watts E; Justice FA; Clifford V; Cowley D; Buttery JP; Bines JE
    Vaccine; 2013 May; 31(23):2610-6. PubMed ID: 23597719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: A double-blind, parallel group, randomized, controlled trial.
    Lee B; Dickson DM; Alam M; Afreen S; Kader A; Afrin F; Ferdousi T; Damon CF; Gullickson SK; McNeal MM; Bak DM; Tolba M; Carmolli MP; Taniuchi M; Haque R; Kirkpatrick BD
    Vaccine; 2020 Jan; 38(1):90-99. PubMed ID: 31607603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries.
    Baker JM; Tate JE; Leon J; Haber MJ; Lopman BA
    PLoS Med; 2019 Dec; 16(12):e1003005. PubMed ID: 31887139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of different dosing schedules of the human live attenuate rotavirus vaccine (RV1) in infants and children: a meta-analysis.
    Dai X; Bai R; Jian M; Ji Z; Ding Z; Wang F; Bi Y; Manzamaesso A; Chen T; Luo L; Liu A; Bao F
    Hum Vaccin Immunother; 2019; 15(6):1228-1236. PubMed ID: 30346870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.